Impact of Postprocedural TIMI Flow on Long-Term Clinical Outcomes in Patients with Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Impact of Postprocedural TIMI Flow on Long-Term Clinical Outcomes in Patients with Acute Myocardial Infarction

Published:2017 Issue:5 Volume:58 Page:674-685
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Kim Dae-Won¹,Her Sung-Ho¹,Park Mahn-Won¹,Cho Jung Sun¹,Kim Tae-Seok¹,Kang Hyeonjeong¹,Sim Doo Sun²,Hong Young Joon²,Kim Ju Han²,Ahn Youngkeun²,Chang Kiyuk³,Chung Wook-Sung³,Seung Ki-Bae³,Jeong Myung-Ho²,Rho Tai-Ho⁴

Affiliation:

1. Division of Cardiology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea

2. Cardiovascular Center, Chonnam National University Hospital, Chonnam National University

3. Division of Cardiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea

4. Division of Cardiology, Seoul St. Paul's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/58/5/58_16-448/_pdf

Reference41 articles.

1. 1. Ross AM, Simoons ML, et al. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med 1993; 329: 1615-22.

2. 2. Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993; 21: 1391-5.

3. 3. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.

4. 4. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413-9.

5. 5. Kenner MD, Zajac EJ, Kondos GT, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995; 76: 861-8.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk assessment for mortality in patients with ST‐elevation myocardial infarction undergoing primary percutaneous coronary intervention: A retrospective cohort study;Health Science Reports;2024-02

2. Long-term clinical outcomes in patients with non-ST-segment Elevation Acute Coronary Syndrome and ST-segment elevation myocardial infarction with thrombolysis in myocardial infarction 0 flow;IJC Heart & Vasculature;2023-10

3. Successful visible thrombus aspiration in ST-segment elevation myocardial infarction: associated factors and the clinical impact;Coronary Artery Disease;2022-07-08

4. The Clinical Efficacy of Tirofiban Combined with Ticagrelor and Aspirin in Treating Acute Myocardial Infarction by Percutaneous Coronary Intervention and Its Effect on Patients’ Cardiac Function;Journal of Healthcare Engineering;2022-02-09

5. Comparison of door-to-balloon time and in-hospital outcomes in patients with ST-elevation myocardial infarction between before versus after COVID-19 pandemic;Cardiovascular Intervention and Therapeutics;2022-01-10